ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 110 filers reported holding ATARA BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $71,536 | -3.4% | 48,335 | +5.1% | 0.00% | – |
| Q2 2023 | $74,023 | -43.9% | 45,977 | +1.1% | 0.00% | -100.0% |
| Q1 2023 | $131,938 | -8.3% | 45,496 | +3.7% | 0.00% | 0.0% |
| Q4 2022 | $143,874 | -13.3% | 43,864 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $166,000 | -50.4% | 44,024 | +2.5% | 0.00% | -50.0% |
| Q2 2022 | $335,000 | -16.5% | 42,962 | -0.4% | 0.00% | 0.0% |
| Q1 2022 | $401,000 | -44.9% | 43,148 | -6.6% | 0.00% | -50.0% |
| Q4 2021 | $728,000 | -10.1% | 46,186 | +2.1% | 0.00% | 0.0% |
| Q3 2021 | $810,000 | +12.5% | 45,233 | -2.3% | 0.00% | +100.0% |
| Q2 2021 | $720,000 | +7.3% | 46,307 | -0.9% | 0.00% | 0.0% |
| Q1 2021 | $671,000 | -22.3% | 46,732 | +6.2% | 0.00% | -33.3% |
| Q4 2020 | $864,000 | +54.0% | 43,999 | +1.7% | 0.00% | 0.0% |
| Q3 2020 | $561,000 | +9.6% | 43,279 | +23.2% | 0.00% | +50.0% |
| Q2 2020 | $512,000 | +97.7% | 35,115 | +15.2% | 0.00% | +100.0% |
| Q1 2020 | $259,000 | -51.2% | 30,478 | -5.5% | 0.00% | -50.0% |
| Q4 2019 | $531,000 | +15.7% | 32,240 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $459,000 | -19.0% | 32,511 | +15.3% | 0.00% | 0.0% |
| Q2 2019 | $567,000 | -46.7% | 28,209 | +5.5% | 0.00% | -50.0% |
| Q1 2019 | $1,063,000 | +10.8% | 26,749 | -3.1% | 0.00% | 0.0% |
| Q4 2018 | $959,000 | -16.7% | 27,616 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $1,151,000 | +18.3% | 27,828 | +5.1% | 0.00% | +33.3% |
| Q2 2018 | $973,000 | +18.7% | 26,486 | +25.9% | 0.00% | 0.0% |
| Q1 2018 | $820,000 | +151.5% | 21,033 | +16.7% | 0.00% | +200.0% |
| Q4 2017 | $326,000 | +15.2% | 18,016 | +5.5% | 0.00% | 0.0% |
| Q3 2017 | $283,000 | +28.1% | 17,080 | +8.1% | 0.00% | 0.0% |
| Q2 2017 | $221,000 | -24.8% | 15,803 | +10.5% | 0.00% | 0.0% |
| Q1 2017 | $294,000 | +54.7% | 14,304 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $190,000 | -99.9% | 13,356 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $286,433,000 | -4.8% | 13,391 | +0.1% | 0.00% | 0.0% |
| Q2 2016 | $300,981,000 | +53.6% | 13,371 | +30.3% | 0.00% | 0.0% |
| Q1 2016 | $196,000,000 | -18.0% | 10,260 | +13.5% | 0.00% | 0.0% |
| Q4 2015 | $239,000,000 | +84352.3% | 9,043 | +0.5% | 0.00% | 0.0% |
| Q3 2015 | $283,000 | -99.9% | 9,002 | +0.1% | 0.00% | -50.0% |
| Q2 2015 | $474,418,000 | +215.7% | 8,992 | +148.7% | 0.00% | +100.0% |
| Q1 2015 | $150,276,000 | +55.4% | 3,615 | 0.0% | 0.00% | – |
| Q4 2014 | $96,701,000 | – | 3,615 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KPCB XV Associates, LLC | 1,876,650 | $29,576,000 | 23.33% |
| Antipodean Advisors LLC | 1,000,000 | $15,760,000 | 6.47% |
| M28 Capital Management LP | 456,865 | $7,200,000 | 5.62% |
| Redmile Group, LLC | 6,437,777 | $101,459,000 | 2.31% |
| One Fin Capital Management LP | 303,000 | $4,775,000 | 1.99% |
| MAVERICK CAPITAL LTD | 7,855,824 | $123,808,000 | 1.40% |
| Baupost Group | 8,477,488 | $133,605,000 | 1.32% |
| BRIDGER MANAGEMENT, LLC | 616,488 | $9,716,000 | 1.26% |
| 683 Capital Management, LLC | 1,781,234 | $28,073,000 | 1.03% |
| Trellus Management Company, LLC | 95,000 | $1,497,000 | 1.00% |